Bicara Therapeutics Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Boston, MA
SEC filing record 1 source field available
Fiscal year end
31 December
Bicara Therapeutics Inc. has filed 245 SEC EDGAR filings since 10 Jun 2024

SEC filing history

Showing 51-75 of 245 matching filings.

Per page
25
Current page
3
4

FORM 4

Filing date
17 Apr 2026
Reporting date
15 Apr 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-42271

144 filing

Filing date
15 Apr 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G/A File 005-94620

SCHEDULE 13G/A filing

Filing date
08 Apr 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
26 Mar 2026
Reporting date
25 Mar 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-42271

144 filing

Filing date
25 Mar 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
24 Mar 2026
Reporting date
23 Mar 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-42271

144 filing

Filing date
23 Mar 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
20 Mar 2026
Reporting date
18 Mar 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-42271

144 filing

Filing date
20 Mar 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-42271

144 filing

Filing date
19 Mar 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-42271

144 filing

Filing date
18 Mar 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
17 Mar 2026
Reporting date
16 Mar 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-42271

144 filing

Filing date
16 Mar 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
11 Mar 2026
Reporting date
09 Mar 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-42271

144 filing

Filing date
09 Mar 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
06 Mar 2026
Reporting date
04 Mar 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-42271

144 filing

Filing date
06 Mar 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
05 Mar 2026
Reporting date
03 Mar 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
05 Mar 2026
Reporting date
03 Mar 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
05 Mar 2026
Reporting date
03 Mar 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-42271

144 filing

Filing date
05 Mar 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-42271

144 filing

Filing date
04 Mar 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .